scispace - formally typeset
P

Pei-Zhuo Zhang

Researcher at University of Science and Technology of China

Publications -  20
Citations -  1180

Pei-Zhuo Zhang is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Small interfering RNA & Gene silencing. The author has an hindex of 13, co-authored 20 publications receiving 1100 citations.

Papers
More filters
Journal ArticleDOI

Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression

TL;DR: Clear evidence is shown that the micelleplex is capable of delivering siRNA and paclitaxel simultaneously to the same tumoral cells both in vitro and in vivo and can induce a synergistic tumor suppression effect in the MDA-MB-435s xenograft murine model.
Journal ArticleDOI

Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.

TL;DR: Without exhibiting cellular toxicity, PEI-capped AuNPs appear to be suitable as a potential carrier for intracellular siRNA delivery.
Journal ArticleDOI

A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.

TL;DR: A micelleplex system based on an amphiphilic and cationic triblock copolymer, which can systemically deliver siRNA targeting the acid ceramidase (AC) gene for cancer therapy, and is found to induce remarkable apoptosis and reduce the proliferation of cancer cells.
Journal ArticleDOI

Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles.

TL;DR: A PEGylated LPH nanoparticle formulation modified with cyclic RGD peptide (cRGD) for specific and efficient delivery of AMO into endothelial cells, targeting α(v)β₃ integrin present on the tumor neovasculature is reported.
Journal ArticleDOI

Synthetic Lethal Therapy for KRAS Mutant Non-small-cell Lung Carcinoma with Nanoparticle-mediated CDK4 siRNA Delivery

TL;DR: Systemic delivery of micellar nanoparticles containing small interfering RNA targeting CDK4 significantly inhibited tumor growth in an A549 NSCLC xenograft murine model, suggesting the therapeutic promise of MNPsiCDK4 delivery in KRAS mutant NSCLCs via a synthetic lethal interaction between KRAS and CDK 4.